REGN logo

REGN Return On Equity

Annual ROE:

15.95%-0.31%(-1.91%)
December 31, 2024

Summary

  • As of today, REGN annual return on equity is 15.95%, with the most recent change of -0.31% (-1.91%) on December 31, 2024.
  • During the last 3 years, REGN annual ROE has fallen by -38.26% (-70.58%).
  • REGN annual ROE is now -81.60% below its all-time high of 86.68%, reached on December 31, 2012.

Performance

REGN ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherREGNprofitability metrics

Quarterly ROE:

15.37%+0.12%(+0.79%)
September 30, 2025

Summary

  • As of today, REGN quarterly return on equity is 15.37%, with the most recent change of +0.12% (+0.79%) on September 30, 2025.
  • Over the past year, REGN quarterly ROE has dropped by -1.82% (-10.59%).
  • REGN quarterly ROE is now -85.10% below its all-time high of 103.18%, reached on December 31, 2012.

Performance

REGN Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherREGNprofitability metrics

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

REGN ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year-1.9%-10.6%
3Y3 Years-70.6%-43.9%
5Y5 Years-25.2%-48.5%

REGN ROE Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-70.6%at low-43.9%+0.8%
5Y5-Year-70.6%at low-71.8%+0.8%
All-TimeAll-Time-81.6%+121.0%-85.1%+115.1%

REGN ROE History

DateAnnualQuarterly
Sep 2025
-
15.37%(+0.8%)
Jun 2025
-
15.25%(-2.9%)
Mar 2025
-
15.70%(-0.5%)
Dec 2024
15.95%(-1.9%)
15.78%(-8.2%)
Sep 2024
-
17.19%(+3.5%)
Jun 2024
-
16.61%(+8.0%)
Mar 2024
-
15.38%(-5.8%)
Dec 2023
16.26%(-22.3%)
16.33%(-4.7%)
Sep 2023
-
17.13%(-10.5%)
Jun 2023
-
19.14%(-1.0%)
Mar 2023
-
19.33%(-7.8%)
Dec 2022
20.94%(-61.4%)
20.96%(-23.4%)
Sep 2022
-
27.38%(-11.6%)
Jun 2022
-
30.99%(-35.1%)
Mar 2022
-
47.77%(-12.3%)
Dec 2021
54.21%(+70.6%)
54.45%(+2.0%)
Sep 2021
-
53.39%(-1.4%)
Jun 2021
-
54.14%(+46.9%)
Mar 2021
-
36.86%(+12.1%)
Dec 2020
31.77%(+49.0%)
32.88%(+10.3%)
Sep 2020
-
29.82%(+5.0%)
Jun 2020
-
28.39%(+31.9%)
Mar 2020
-
21.53%(+0.8%)
Dec 2019
21.32%(-35.0%)
21.35%(-7.7%)
Sep 2019
-
23.14%(-3.8%)
Jun 2019
-
24.05%(-21.1%)
Mar 2019
-
30.48%(-8.9%)
Dec 2018
32.81%(+45.0%)
33.46%(+25.9%)
Sep 2018
-
26.58%(+5.1%)
Jun 2018
-
25.28%(+3.2%)
Mar 2018
-
24.49%(+10.5%)
Dec 2017
22.63%(+2.4%)
22.17%(-12.0%)
Sep 2017
-
25.18%(+2.1%)
Jun 2017
-
24.67%(+10.9%)
Mar 2017
-
22.24%(+1.5%)
Dec 2016
22.10%(+7.6%)
21.91%(+6.0%)
Sep 2016
-
20.67%(+0.9%)
Jun 2016
-
20.49%(-5.9%)
Mar 2016
-
21.77%(+8.2%)
Dec 2015
20.53%(+32.5%)
20.12%(+0.0%)
Sep 2015
-
20.11%(+20.3%)
Jun 2015
-
16.72%(+17.9%)
Mar 2015
-
14.18%(-5.3%)
Dec 2014
15.49%(-41.6%)
14.97%(-3.6%)
Sep 2014
-
15.53%(-23.8%)
Jun 2014
-
20.39%(-8.7%)
Mar 2014
-
22.33%(-18.1%)
Dec 2013
26.54%(-69.4%)
27.25%(-54.6%)
Sep 2013
-
60.08%(-21.4%)
Jun 2013
-
76.47%(-16.8%)
Mar 2013
-
91.90%(-10.9%)
Dec 2012
86.68%(+298.1%)
103.18%(+156.9%)
Sep 2012
-
40.16%(+830.2%)
Jun 2012
-
-5.50%(+84.1%)
Mar 2012
-
-34.52%(+24.1%)
Dec 2011
-43.76%(-93.6%)
-45.48%(-14.4%)
Sep 2011
-
-39.76%(-15.5%)
Jun 2011
-
-34.42%(-26.2%)
Mar 2011
-
-27.28%(-6.0%)
Dec 2010
-22.60%(-35.9%)
-25.73%(+21.6%)
Sep 2010
-
-32.82%(-39.5%)
Jun 2010
-
-23.53%(-14.9%)
Mar 2010
-
-20.47%(-24.3%)
Dec 2009
-16.63%(+11.6%)
-16.47%(-10.0%)
Sep 2009
-
-14.97%(+23.2%)
Jun 2009
-
-19.50%(+1.8%)
Mar 2009
-
-19.86%(-7.0%)
Dec 2008
-18.82%
-18.56%(-13.2%)
Sep 2008
-
-16.39%(+29.4%)
Jun 2008
-
-23.20%(+23.0%)
DateAnnualQuarterly
Mar 2008
-
-30.14%(+31.3%)
Dec 2007
-31.20%(+50.0%)
-43.84%(+42.7%)
Sep 2007
-
-76.56%(+1.7%)
Jun 2007
-
-77.87%(+7.9%)
Mar 2007
-
-84.51%(+5.1%)
Dec 2006
-62.40%(+3.1%)
-89.05%(+12.8%)
Sep 2006
-
-102.07%(-12.6%)
Jun 2006
-
-90.68%(-13.4%)
Mar 2006
-
-79.96%(-31.3%)
Dec 2005
-64.37%(-347.1%)
-60.89%(-64.1%)
Sep 2005
-
-37.11%(-70.0%)
Jun 2005
-
-21.83%(-52.4%)
Mar 2005
-
-14.32%(-161.4%)
Dec 2004
26.05%(+134.4%)
23.34%(+107.3%)
Sep 2004
-
11.26%(+480.4%)
Jun 2004
-
1.94%(+128.3%)
Mar 2004
-
-6.85%(+90.4%)
Dec 2003
-75.78%(-25.6%)
-71.05%(+8.4%)
Sep 2003
-
-77.53%(-2.7%)
Jun 2003
-
-75.50%(-10.9%)
Mar 2003
-
-68.06%(-14.8%)
Dec 2002
-60.33%(-77.6%)
-59.30%(-21.3%)
Sep 2002
-
-48.87%(-24.8%)
Jun 2002
-
-39.16%(-27.4%)
Mar 2002
-
-30.73%(-11.4%)
Dec 2001
-33.97%(-128.8%)
-27.58%(-28.0%)
Sep 2001
-
-21.54%(-29.3%)
Jun 2001
-
-16.66%(-18.0%)
Mar 2001
-
-14.12%(+1.6%)
Dec 2000
-14.85%(+22.5%)
-14.35%(-33.7%)
Sep 2000
-
-10.73%(+20.1%)
Jun 2000
-
-13.43%(+29.4%)
Mar 2000
-
-19.01%(+2.8%)
Dec 1999
-19.16%(-199.8%)
-19.55%(+11.3%)
Sep 1999
-
-22.05%(-20.0%)
Jun 1999
-
-18.38%(-78.1%)
Mar 1999
-
-10.32%(-62.0%)
Dec 1998
-6.39%(+32.2%)
-6.37%(-237.0%)
Sep 1998
-
-1.89%(+16.0%)
Jun 1998
-
-2.25%(+69.1%)
Mar 1998
-
-7.27%(+21.7%)
Dec 1997
-9.42%(+74.6%)
-9.28%(+45.8%)
Sep 1997
-
-17.11%(+28.9%)
Jun 1997
-
-24.08%(+23.1%)
Mar 1997
-
-31.31%(+12.3%)
Dec 1996
-37.10%(-6.5%)
-35.69%(+11.1%)
Sep 1996
-
-40.13%(+5.9%)
Jun 1996
-
-42.65%(+3.6%)
Mar 1996
-
-44.25%(-17.2%)
Dec 1995
-34.84%(+6.0%)
-37.76%(-11.0%)
Sep 1995
-
-34.01%(-25.6%)
Jun 1995
-
-27.08%(+17.9%)
Mar 1995
-
-32.97%(+13.7%)
Dec 1994
-37.05%(+13.8%)
-38.22%(+6.6%)
Sep 1994
-
-40.94%(+14.2%)
Jun 1994
-
-47.71%(-2.2%)
Mar 1994
-
-46.67%(-3.6%)
Dec 1993
-42.99%(-117.5%)
-45.03%(-13.4%)
Sep 1993
-
-39.70%(-9.5%)
Jun 1993
-
-36.25%(-32.6%)
Mar 1993
-
-27.34%(-39.3%)
Dec 1992
-19.77%(-160.1%)
-19.62%(-34.4%)
Sep 1992
-
-14.60%(-53.7%)
Jun 1992
-
-9.50%(-26.3%)
Mar 1992
-
-7.52%(-43.5%)
Dec 1991
-7.60%(+71.9%)
-5.24%(-25.4%)
Sep 1991
-
-4.18%(+18.0%)
Jun 1991
-
-5.10%(+82.7%)
Mar 1991
-
-29.51%(-9.1%)
Dec 1990
-27.05%
-27.05%

FAQ

  • What is Regeneron Pharmaceuticals, Inc. annual return on equity?
  • What is the all-time high annual ROE for Regeneron Pharmaceuticals, Inc.?
  • What is Regeneron Pharmaceuticals, Inc. annual ROE year-on-year change?
  • What is Regeneron Pharmaceuticals, Inc. quarterly return on equity?
  • What is the all-time high quarterly ROE for Regeneron Pharmaceuticals, Inc.?
  • What is Regeneron Pharmaceuticals, Inc. quarterly ROE year-on-year change?

What is Regeneron Pharmaceuticals, Inc. annual return on equity?

The current annual ROE of REGN is 15.95%

What is the all-time high annual ROE for Regeneron Pharmaceuticals, Inc.?

Regeneron Pharmaceuticals, Inc. all-time high annual return on equity is 86.68%

What is Regeneron Pharmaceuticals, Inc. annual ROE year-on-year change?

Over the past year, REGN annual return on equity has changed by -0.31% (-1.91%)

What is Regeneron Pharmaceuticals, Inc. quarterly return on equity?

The current quarterly ROE of REGN is 15.37%

What is the all-time high quarterly ROE for Regeneron Pharmaceuticals, Inc.?

Regeneron Pharmaceuticals, Inc. all-time high quarterly return on equity is 103.18%

What is Regeneron Pharmaceuticals, Inc. quarterly ROE year-on-year change?

Over the past year, REGN quarterly return on equity has changed by -1.82% (-10.59%)
On this page